Differential regulation of 11β-hydroxysteroid dehydrogenase type-1 and -2 gene transcription by proinflammatory cytokines in vascular smooth muscle cells

Life Sciences

Volumn 83, Issue 11-12, 2008, Pages 426-432

  Tsugita, Makoto ^a   Iwasaki, Yasumasa ^a   Nishiyama, Mitsuru ^a   Taguchi, Takafumi ^a   Shinahara, Masayuki ^a   Taniguchi, Yoshinori ^a   Kambayashi, Machiko ^a   Terada, Yoshio ^a   Hashimoto, Kozo ^a  

^a KOCHI UNIVERSITY   (Japan)

Author keywords

11 hydroxysteroid dehydrogenase; Cytokine; Glucocortcoid; Smooth muscle

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CCAAT ENHANCER BINDING PROTEIN; CORTISONE; CYTOKINE; EARLY GROWTH RESPONSE FACTOR 1; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SP1; TUMOR NECROSIS FACTOR ALPHA; LUCIFERASE;

ANIMAL TISSUE; AORTA; ARTICLE; BIOASSAY; CYTOKINE PRODUCTION; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; IN VITRO STUDY; NONHUMAN; RAT; RECEPTOR GENE; STIMULUS; STRESS; VASCULAR SMOOTH MUSCLE; BIOSYNTHESIS; CELL LINE; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PLASMID; PROMOTER REGION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; STIMULATION; WESTERN BLOTTING;

RATTUS;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE; CYTOKINES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENES, REPORTER; HUMANS; LUCIFERASES; MOLECULAR SEQUENCE DATA; MYOCYTES, SMOOTH MUSCLE; PLASMIDS; PROMOTER REGIONS (GENETICS); RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STIMULATION, CHEMICAL; TRANSCRIPTION FACTOR AP-1; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 50849145155     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.07.005     Document Type: Article

References (37)

1. Alikhani-Koopaei R., Fouladkou F., Frey F.J., and Frey B.M. Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression. Journal of Clinical Investigation 114 8 (2004) 1146-1157
2. Alikhani-Koupaei R., Fouladkou F., Fustier P., Cenni B., Sharma A.M., Deter H.C., Frey B.M., and Frey F.J. Identification of polymorphisms in the human 11beta-hydroxysteroid dehydrogenase type 2 gene promoter: functional characterization and relevance for salt sensitivity. FASEB Journal 21 13 (2007) 3618-3628
3. Aoki Y., Iwasaki Y., Katahira M., 0iso Y., and Saito H. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. I: Effects of the common secretagogues. Endocrinology 138 5 (1997) 1923-1929
4. Bahouth S.W., Beauchamp M.J., and Vu K.N. Reciprocal regulation of beta(1)-adrenergic receptor gene transcription by Sp1 and early growth response gene 1: induction of EGR-1 inhibits the expression of the beta(1)-adrenergic receptor gene. Molecular Pharmacology 61 2 (2002) 379-390
5. Bujalska I.J., Quinkler M., Tomlinson J.W., Montague C.T., Smith D.M., and Stewart P.M. Expression profiling of 11beta-hydroxysteroid dehydrogenase type-1 and glucocorticoid-target genes in subcutaneous and omental human preadipocytes. Journal of Molecular Endocrinology 37 2 (2006) 327-340
6. Bujalska, I.J., Kumar, S., Stewart, P.M., 1997. Does central obesity reflect "Cushing's disease of the omentum"? Lancet Apr 26 1997; 349(9060):1210-3.
7. Cai T.Q., Wong B., Mundt S.S., Thieringer R., Wright S.D., and Hermanowski-Vosatka A. Induction of 11beta-hydroxysteroid dehydrogenase type 1 but not -2 in human aortic smooth muscle cells by inflammatory stimuli. Journal of Steroid Biochemistry and Molecular Biology 77 2-3 (2001) 117-122
8. Chapman K.E., Coutinho A., Gray M., Gilmour J.S., Savill J.S., and Seckl J.R. Local amplification of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 and its role in the inflammatory response. Annals of the New York Academy of Sciences 1088 (2006) 265-273
9. Davis Jr. W., Chen Z.J., Ile K.E., and Tew K.D. Reciprocal regulation of expression of the human adenosine 5′-triphosphate binding cassette, sub-family A, transporter 2 (ABCA2) promoter by the early growth response-1 (EGR-1) and Sp-family transcription factors. Nucleic Acids Research 31 3 (2003) 1097-1107
10. de Kloet E.R., Reul J.M., de Ronde F.S., Bloemers M., and Ratka A. Function and plasticity of brain corticosteroid receptor systems: action of neuropeptides. Journal of Steroid Biochemistry 25 5B (1986) 723-731
11. Draper N., and Stewart P.M. 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action. Journal of Endocrinology 186 2 (2005) 251-271
12. Feinberg M.W., Watanabe M., Lebedeva M.A., Depina A.S., Hanai J., Mammoto T., Frederick J.P., Wang X.F., Sukhatme V.P., and Jain M.K. Transforming growth factor-beta1 inhibition of vascular smooth muscle cell activation is mediated via Smad3. Journal of Biological Chemistry 279 16 (2004) 16388-16393
13. Fu M., Zhang J., Lin Y., Zhu X., Ehrengruber M.U., and Chen Y.E. Early growth response factor-1 is a critical transcriptional mediator of peroxisome proliferator-activated receptor-gamma 1 gene expression in human aortic smooth muscle cells. Journal Biological Chemistry 277 30 (2002) 26808-26814
14. Fukuoka T., Kitami Y., 0kura T., and Hiwada K. Transcriptional regulation of the platelet-derived growth factor alpha receptor gene via CCAAT/enhancer-binding protein-delta in vascular smooth muscle cells. Journal Biological Chemistry 274 36 (1999) 25576-25582
15. Funder J.W. RALES, EPHESUS and redox. Journal Steroid Biochemistry and Molecular Biology 93 2-5 (2005) 121-125
16. Funder J.W. Mineralocorticoid receptors and cardiovascular damage: it's not just aldosterone. Hypertension 47 4 (2006) 656-664
17. Goetze S., Kintscher U., Kaneshiro K., Meehan W.P., Collins A., Fleck E., Hsueh W.A., Hecker M., Preiss C., and Schini-Kerth V.B. Induction by staurosporine of nitric oxide synthase expression in vascular smooth muscle cells: role of NF-kappa B, CREB and C/EBP beta. British Journal of Pharmacology 120 6 (1997) 1067-1074
18. Gout J., Tirard J., Thévenon C., Riou J.P., Bégeot M., and Naville D. CCAAT/enhancer-binding proteins (C/EBPs) regulate the basal and cAMP-induced transcription of the human 11beta-hydroxysteroid dehydrogenase encoding gene in adipose cells. Biochimie 88 9 (2006) 1115-1124
19. Hecker M., Preiss C., and Schini-Kerth V.B. Induction by staurosporine of nitric oxide synthase expression in vascular smooth muscle cells: role of NF-kappa B, CREB and C/EBP beta. British Journal of Pharmacology 120 6 (1997) 1067-1074
20. Hewitt K.N., Walker E.A., and Stewart P.M. Hexose-6-phosphate dehydrogenase and redox control of 11{beta}-hydroxysteroid dehydrogenase type 1 activity. Endocrinology 146 6 (2005) 2539-2543
21. Iwasaki Y., Takayasu S., Nishiyama M., Tsugita M., Taguchi T., Asai M., Yoshida M., Kambayashi M., and Hashimoto K. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene. Molecular and Cellular Endocrinology 285 1-2 (2008) 10-18
22. Jaffe I.Z., and Mendelsohn M.E. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells. Circulation Research 96 6 (2005) 643-650
23. Kostadinova R.M., Nawrocki A.R., Frey F.J., and Frey B.M. Tumor necrosis factor alpha and phorbol 12-myristate-13-acetate down-regulate human 11beta-hydroxysteroid dehydrogenase type 2 through p50/p50 NF-kappaB homodimers and Egr-1. FASEB Journal 19 6 (2005) 650-652
24. Law R.E. TNFalpha induces expression of transcription factors c-fos, Egr-1, and Ets-1 in vascular lesions through extracellular signal-regulated kinases 1/2. Atherosclerosis 159 1 (2001) 93-101
25. Li W., Gao L., Wang Y., Duan T., Myatt L., and Sun K. Enhancement of cortisol-induced 11beta-hydroxysteroid dehydrogenase type 1 expression by interleukin 1beta in cultured human chorionic trophoblast cells. Endocrinology 147 5 (2006) 2490-2495
26. Masuzaki H., Paterson J., Shinyama H., Morton N.M., Mullins J.J., Seckl J.R., and Flier J.S. A transgenic model of visceral obesity and the metabolic syndrome. Science 294 5549 (2001) 2166-2170
27. Matsuzawa Y. Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nature Clinical Pracice. Cardiovascular Medicine 3 1 (2006) 35-42
28. Rocha R., and Stier Jr. C.T. Pathophysiological effects of aldosterone in cardiovascular tissues. Trends in Endocrinology and Metabolism 12 7 (2001) 308-314
29. Rocha R., Rudolph A.E., Frierdich G.E., Nachowiak D.A., Kekec B.K., Blomme E.A., McMahon E.G., and Delyani J.A. Aldosterone induces a vascular inflammatory phenotype in the rat heart. American Journal of Physiology Heart and Circulatory Physiology 283 5 (2002) H1802-H1810
30. Stimson R.H., and Walker B.R. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome. Minerva Endocrinologica 32 3 (2007) 141-159
31. Takeda Y. Vascular synthesis of aldosterone: role in hypertension. Molecular and Cellular Endocrinology 217 1-2 (2004) 75-79
32. Tan L., Peng H., 0saki M., Choy B.K., Auron P.E., Sandell L.J., and Goldring M.B. Egr-1 mediates transcriptional repression of C0L2A1 promoter activity by interleukin-1beta. Journal of Biological Chemistry 278 20 (2003) 17688-17700
33. White P.C. 11beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess. American Journal of Medical Sciences 322 6 (2001) 308-315
34. Williams L.J., Lyons V., MacLeod I., Rajan V., Darlington G.J., Poli V., Seckl J.R., and Chapman K.E. C/EBP regulates hepatic transcription of 11beta-hydroxysteroid dehydrogenase type 1. A novel mechanism for cross-talk between the C/EBP and glucocorticoid signaling pathways. Journal of Biological Chemistry 275 39 (2000) 30232-30239
35. Yang S., and Zhang L. Glucocorticoids and vascular reactivity. Currrent Vascular Pharmacology 2 1 (2004) 1-12
36. Yudkin J.S. Inflammation, obesity, and the metabolic syndrome. Hormone and Metabolic Research 39 10 (2007) 707-709
37. Zhang X., and Liu Y. Suppression of HGF receptor gene expression by oxidative stress is mediated through the interplay between Sp1 and Egr-1. American Journal of Physiology. Renal Physiology 284 6 (2003) F1216-F1325